---
title: "Clobetasol - Dermatitis, Seborrheic - 2"
sidebar: mydoc_sidebar
permalink: db11750-mesh-d012628-2.html
toc: false 
---


Path ID: `DB11750_MESH_D012628_2`
{% include image.html url="images/db11750-mesh-d012628-2.png" file="db11750-mesh-d012628-2.png" alt="db11750-mesh-d012628-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D002990">MESH:D002990 </a> | Clobetasol | Drug |
| <a href="https://identifiers.org/UniProt:P04150">UniProt:P04150 </a> | Glucocorticoid receptor | Protein |
| <a href="https://identifiers.org/MESH:D016753">MESH:D016753 </a> | Interleukin-10 | ChemicalSubstance |
| <a href="https://identifiers.org/InterPro:IPR000451">InterPro:IPR000451 </a> | NF-kappa-B/Dorsal | GeneFamily |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/HP:0011123">HP:0011123 </a> | Inflammatory abnormality of the skin | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D012628">MESH:D012628 </a> | Dermatitis, Seborrheic | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Clobetasol | INCREASES ACTIVITY OF | Glucocorticoid Receptor |
| Glucocorticoid Receptor | INCREASES ACTIVITY OF | Interleukin-10 |
| Interleukin-10 | NEGATIVELY REGULATES | Nf-Kappa-B/Dorsal |
| Nf-Kappa-B/Dorsal | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Inflammatory Abnormality Of The Skin |
| Inflammatory Abnormality Of The Skin | CONTRIBUTES TO | Dermatitis, Seborrheic |
|---------|-----------|---------|

Comment: Clobetasol is under investigation for the treatment of Scleroderma. Clobetasol propionate is a propionate ester of clobetasol which act as a glucocorticoid receptor and approved for the treatment of dermatoses.

Reference: 
  - [https://go.drugbank.com/drugs/DB11750#mechanism-of-action](https://go.drugbank.com/drugs/DB11750#mechanism-of-action)
  - [https://go.drugbank.com/drugs/DB01013#mechanism-of-action](https://go.drugbank.com/drugs/DB01013#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Clobetasol](https://en.wikipedia.org/wiki/Clobetasol)
  - [https://www.uniprot.org/uniprot/P04150#function](https://www.uniprot.org/uniprot/P04150#function)
  - [https://pubmed.ncbi.nlm.nih.gov/7721885/](https://pubmed.ncbi.nlm.nih.gov/7721885/)
  - [https://en.wikipedia.org/wiki/Seborrhoeic_dermatitis](https://en.wikipedia.org/wiki/Seborrhoeic_dermatitis)
